Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
International Journal of Molecular Sciences · 14.10.2023 · 24 (20) · 15193
DOI: 10.3390/ijms242015193 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.10.2023. Verfasst von Lissuly Guadalupe Álvarez-Hilario und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico C.P. 0736…. Hauptthemen laut MEDLINE: Circulating MicroRNA, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, MicroRNAs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Sectorial de Investigación en Salud y Seguridad Social SS/IMSS/ISSSTE-CONACyt, Consejo Nacional de Ciencia y Tecnología, Consejo Nacional de Ciencia y Tecnología fellowship.
Abstract (Originalsprache)
Among malignant neoplasms, pancreatic ductal adenocarcinoma (PDAC) has one of the highest fatality rates due to its late detection. Therefore, it is essential to discover a noninvasive, early, specific, and sensitive diagnostic method. MicroRNAs (miRNAs) are attractive biomarkers because they are accessible, highly specific, and sensitive. It is crucial to find miRNAs that could be used as possible biomarkers because PDAC is the eighth most common cause of cancer death in Mexico. With the help of microRNA microarrays, differentially expressed miRNAs (DEmiRNAs) were found in PDAC tissues. The presence of these DEmiRNAs in the plasma of Mexican patients with PDAC was determined using RT-qPCR. Receiver operating characteristic curve analysis was performed to determine the diagnostic capacity of these DEmiRNAs. Gene Expression Omnibus datasets (GEO) were employed to verify our results. The Prisma V8 statistical analysis program was used. Four DEmiRNAs in plasma from PDAC patients and microarray tissues were found. Serum samples from patients with PDAC were used to validate their overexpression in GEO databases. We discovered a new panel of the two miRNAs miR-222-3p and miR-221-3p that could be used to diagnose PDAC, and when miR-221-3p and miR-222-3p were overexpressed, survival rates decreased. Therefore, miR-222-3p and miR-221-3p might be employed as noninvasive indicators for the diagnosis and survival of PDAC in Mexican patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico C.P. 07360, Mexico.
- Coordinación de la Investigación Científica, Red de Apoyo a la Investigación, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de Mexico C.P. 14080, Mexico.
- Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana, Unidad Cuajimalpa, Ciudad de Mexico C.P. 05300, Mexico.
- Departamento de Patología, Instituto Nacional de Cancerología, Ciudad de Mexico C.P. 14080, Mexico.
- Departamento de Patología, Medica Sur Clínica y Fundación, Ciudad de Mexico C.P. 14050, Mexico.
- Servicio de Endoscopía Gastrointestinal, Instituto Nacional de Cancerología, Ciudad de Mexico C.P. 14080, Mexico.
ORCID-Profile: Pedro Antonio Ávila-López, Elena Aréchaga-Ocampo, Roberto Herrera-Goepfert, Héctor Iván Saldívar-Cerón, María Del Rocío Thompson-Bonilla, Miguel Vargas, Rosaura Hernández-Rivas
Förderung
- Fondo Sectorial de Investigación en Salud y Seguridad Social SS/IMSS/ISSSTE-CONACyt
- Consejo Nacional de Ciencia y Tecnología
- Consejo Nacional de Ciencia y Tecnología fellowship
Zitieren
APA
Álvarez-Hilario, L. G., Salmerón-Bárcenas, E. G., Ávila-López, P. A., Hernández-Montes, G., Aréchaga-Ocampo, E., Herrera-Goepfert, R., Albores-Saavedra, J., Manzano-Robleda, M. D. C., Saldívar-Cerón, H. I., Martínez-Frías, S. P., Thompson-Bonilla, M. D. R., Vargas, M., & Hernández-Rivas, R. (2023). Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico. International Journal of Molecular Sciences, 24(20), 15193. https://doi.org/10.3390/ijms242015193
Vancouver
Álvarez-Hilario LG, Salmerón-Bárcenas EG, Ávila-López PA, Hernández-Montes G, Aréchaga-Ocampo E, Herrera-Goepfert R, et al. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico. International Journal of Molecular Sciences. 2023;24(20):15193. doi:10.3390/ijms242015193
BibTeX
@article{lvarezHilario2023,
author = {Álvarez-Hilario, Lissuly Guadalupe and Salmerón-Bárcenas, Eric Genaro and Ávila-López, Pedro Antonio and Hernández-Montes, Georgina and Aréchaga-Ocampo, Elena and Herrera-Goepfert, Roberto and Albores-Saavedra, Jorge and Manzano-Robleda, María Del Carmen and Saldívar-Cerón, Héctor Iván and Martínez-Frías, Sandra Paola and Thompson-Bonilla, María Del Rocío and Vargas, Miguel and Hernández-Rivas, Rosaura},
title = {Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15193},
doi = {10.3390/ijms242015193}
}
EUVIMED